Briefing Information for the May 10, 2018 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
FDA
Akcea Therapeutics, Inc.
Contact Information
- FDA Advisory Committee Information Line
- 1-800-741-8138
- (301-443-0572 in the Washington DC area)
Please call the Information Line for up-to-date information on this meeting.